A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer

Authors: Hickish, T. et al.

Journal: European Journal of Cancer

Volume: 50

Pages: 3136-3144

Source: Manual

Preferred by: Tamas Hickish